The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other conditions with newer weight-loss drugs. The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other conditions with newer weight-loss drugs. Parkinson’s Disease, GLP-1 RAs (Drug), Byetta (Drug), Ozempic (Drug), Clinical Trials, Research, Lancet, The (Journal), your-feed-science NYT > Science
Ozempic-Like Drug Failed to Treat Parkinson’s Disease in Trial
